Martin Eklund

11.0k total citations · 3 hit papers
164 papers, 4.7k citations indexed

About

Martin Eklund is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Martin Eklund has authored 164 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Pulmonary and Respiratory Medicine, 33 papers in Oncology and 27 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Martin Eklund's work include Prostate Cancer Diagnosis and Treatment (77 papers), Prostate Cancer Treatment and Research (69 papers) and Global Cancer Incidence and Screening (27 papers). Martin Eklund is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (77 papers), Prostate Cancer Treatment and Research (69 papers) and Global Cancer Incidence and Screening (27 papers). Martin Eklund collaborates with scholars based in Sweden, United States and Australia. Martin Eklund's co-authors include Henrik Grönberg, Tobias Nordström, Markus Aly, Thomas D. Creekmore, Lars Carlsson, Fredrik Strand, Karin Dembrower, Ulf Norinder, Scott Boyer and Ola Spjuth and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and Nature Communications.

In The Last Decade

Martin Eklund

149 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Factors contributing to healthcare professional burnout during the COVID-19 pandemic: A rapid turnaround global survey

2020 387 citations Luca Morgantini, Ushasi Naha et al. PLoS ONE profile →
Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

2015 282 citations Henrik Grönberg, Markus Aly et al. profile →
MRI-Targeted or Standard Biopsy in Prostate Cancer Screening

2021 230 citations Martin Eklund, Fredrik Jäderling et al. profile →

Peers

Countries citing papers authored by Martin Eklund

Since Specialization

Citations

This map shows the geographic impact of Martin Eklund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Eklund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Eklund more than expected).

Fields of papers citing papers by Martin Eklund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Eklund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Eklund. The network helps show where Martin Eklund may publish in the future.

Co-authorship network of co-authors of Martin Eklund

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Eklund. A scholar is included among the top collaborators of Martin Eklund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Eklund. Martin Eklund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Role of Artificial Intelligence in the Evaluation of Prostate Pathology 2025 ·Pathology International ·Lars Egevad, (unknown), Brett Delahunt, Hemamali Samaratunga, Martin Eklund, Kimmo Kartasalo	0
2	Evaluating the performance of existing tools to predict clinically significant prostate cancer in men with indeterminate lesions on biparametric MRI and development of a novel multiplex model: a prospective cohort study 2025 ·EClinicalMedicine ·(unknown), Martin Eklund, Anna Lantz, Andrea Discacciati, (unknown), (unknown), (unknown), Fredrik Jäderling, Ugo Giovanni Falagario, Henrik Grönberg, Tobias Nordström	1
3	Data Resource Profile: STHLM0, the Stockholm Prostate Cancer Diagnostics Register 2025 ·International Journal of Epidemiology ·(unknown), Martin Eklund, Markus Aly, Mark Clements, Alessio Crippa, Andrea Discacciati, (unknown), (unknown), (unknown), Anna Lantz, Henrik Grönberg, Tobias Nordström	1
4	Gleason scores provide more accurate prognostic information than grade groups 2025 ·Pathology ·Lars Egevad, (unknown), Brett Delahunt, Hemamali Samaratunga, Hans Garmo, Pär Stattin, Martin Eklund	2
5	Hierarchical Vision Transformers for prostate biopsy grading: Towards bridging the generalization gap 2025 ·Medical Image Analysis ·(unknown), Kimmo Kartasalo, Martin Eklund, Lars Egevad, Jeroen van der Laak, Geert Litjens	0
6	Repeated Prostate Cancer Screening Using Prostate-Specific Antigen Testing and Magnetic Resonance Imaging 2024 ·JAMA Network Open ·Tobias Nordström, Magnus Annerstedt, Axel Glaessgen, Stefan Carlsson, Mark Clements, (unknown), Henrik Grönberg, Fredrik Jäderling, Martin Eklund, Andrea Discacciati	17
7	Repeat Prostate Cancer Screening using Blood-based Risk Prediction or Prostate-specific Antigen in the Era of Magnetic Resonance Imaging–guided Biopsies : A Secondary Analysis of the STHLM3-MRI Randomized Clinical Trial 2024 ·European Urology Oncology ·Andrea Discacciati, (unknown), Mark Clements, Magnus Annerstedt, Stefan Carlsson, Henrik Grönberg, Fredrik Jäderling, Martin Eklund, Tobias Nordström	2
8	Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study 2024 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Lars Egevad, (unknown), Brett Delahunt, Hemamali Samaratunga, (unknown), Hans Garmo, Pär Stattin, Martin Eklund	2
9	Anti-CD14 Treatment in Patients With Severe COVID-19 Clinical and Biological Effects in a Phase 2 Randomized Open-Label Adaptive Platform Clinical Trial 2024 ·PubMed ·(unknown), Thomas R. Martin, Carolyn S. Calfee, Kathleen D. Liu, (unknown), Lamorna Brown Swigart, Andrea Discacciati, Martin Eklund, Susan R. Heckbert, Michael A. Matthay, Laura J. Esserman, Mark M. Wurfel	0
10	Effectiveness and Cost-effectiveness of Artificial Intelligence–assisted Pathology for Prostate Cancer Diagnosis in Sweden: A Microsimulation Study 2024 ·European Urology Oncology ·Xiaoyang Du, Shuang Hao, Henrik Olsson, Kimmo Kartasalo, (unknown), (unknown), Dominik Menges, Emelie Heintz, Lars Egevad, Martin Eklund, Mark Clements	8
11	Artificial intelligence for breast cancer detection in screening mammography in Sweden: a prospective, population-based, paired-reader, non-inferiority study 2023 ·The Lancet Digital Health ·Karin Dembrower, Alessio Crippa, Eugenia Colón, Martin Eklund, Fredrik Strand	154
12	Interobserver reproducibility of cribriform cancer in prostate needle biopsies and validation of International Society of Urological Pathology criteria 2023 ·Histopathology ·Lars Egevad, Brett Delahunt, Kenneth A. Iczkowski, Theodorus van der Kwast, Geert J.L.H. van Leenders, Kátia Ramos Moreira Leite, Chin‐Chen Pan, Hemamali Samaratunga, Toyonori Tsuzuki, (unknown), (unknown), Henrik Olsson, Masi Valkonen, Pekka Ruusuvuori, Martin Eklund, Kimmo Kartasalo	4
13	Use of the ISUP e-learning module improves interrater reliability in prostate cancer grading 2022 ·Journal of Clinical Pathology ·(unknown), Lars Egevad, Martin Eklund, Theodorus van der Kwast, Brett Delahunt, Hemamali Samaratunga, Britt B.M. Suelmann, Peter-Paul Willemse, Richard P. Meijer, P. J. van Diest	3
14	Detection of perineural invasion in prostate needle biopsies with deep neural networks 2022 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Kimmo Kartasalo, Peter Ström, Pekka Ruusuvuori, Hemamali Samaratunga, Brett Delahunt, Toyonori Tsuzuki, Martin Eklund, Lars Egevad	16
15	Interobserver reproducibility of perineural invasion of prostatic adenocarcinoma in needle biopsies 2021 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Lars Egevad, Brett Delahunt, Hemamali Samaratunga, Toyonori Tsuzuki, Henrik Olsson, Peter Ström, Cecilia Lindskog, Tomi Häkkinen, Kimmo Kartasalo, Martin Eklund, Pekka Ruusuvuori	12
16	Ethnic variation in prostate cancer detection: A hypothesis generating study for use of the Stockholm3 test in an American cohort 2020 ·European Urology Open Science ·Hari T. Vigneswaran, Andrea Discacciati, (unknown), Henrik Grönberg, Martin Eklund, Michael R. Abern	2
17	Prognostic value of perineural invasion in prostate needle biopsies: a population-based study of patients treated by radical prostatectomy 2020 ·Journal of Clinical Pathology ·Peter Ström, Tobias Nordström, Brett Delahunt, Hemamali Samaratunga, Henrik Grönberg, Lars Egevad, Martin Eklund	12
18	Factors contributing to healthcare professional burnout during the COVID-19 pandemic: A rapid turnaround global survey breakdown → 2020 ·PLoS ONE ·Luca Morgantini, Ushasi Naha, Heng Wang, Simone Francavilla, Ömer Acar, José M. Flores, Simone Crivellaro, Daniel Moreira, Michael R. Abern, Martin Eklund, Hari T. Vigneswaran, Stevan Weine	387
19	The utility of artificial intelligence in the assessment of prostate pathology 2020 ·Histopathology ·Lars Egevad, Peter Ström, Kimmo Kartasalo, Henrik Olsson, Hemamali Samaratunga, Brett Delahunt, Martin Eklund	10
20	SimSel: a new simulation method for variable selection 2011 ·Journal of Statistical Computation and Simulation ·Martin Eklund, Silvelyn Zwanzig	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact